ArticleRecent patents on anti-cancer drug discovery2025

TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification.

Lu Miao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.